Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans.
Deguil J, Ravasi L, Auffret A, Babiloni C, Bartres Faz D, Bragulat V, Cassé-Perrot C, Colavito V, Herrero Ezquerro MT, Lamberty Y, Lanteaume L, Pemberton D, Pifferi F, Richardson JC, Schenker E, Blin O, Tarragon E, Bordet R. Deguil J, et al. Among authors: bartres faz d. Drug Discov Today Technol. 2013 Sep;10(3):e329-42. doi: 10.1016/j.ddtec.2013.03.003. Drug Discov Today Technol. 2013. PMID: 24179995 Review.
A review of the effects of hypoxia, sleep deprivation and transcranial magnetic stimulation on EEG activity in humans: challenges for drug discovery for Alzheimer's disease.
Babiloni C, Del Percio C, Lizio R, Infarinato F, Blin O, Bartres-Faz D, Dix SL, Bentivoglio M, Soricelli A, Bordet R, Rossini PM, Richardson JC. Babiloni C, et al. Among authors: bartres faz d. Curr Alzheimer Res. 2014;11(5):501-18. doi: 10.2174/1567205011666140317095623. Curr Alzheimer Res. 2014. PMID: 24635844 Review.
Neurobehavioral and Cognitive Changes Induced by Hypoxia in Healthy Volunteers.
Lanteaume L, Cassé-Perrot C, Lefebvre MN, Audebert C, Deguil J, Auffret A, Otten L, Bartrés-Faz D, Blin O, Bordet R, Micallef J. Lanteaume L, et al. Among authors: bartres faz d. CNS Neurol Disord Drug Targets. 2016;15(7):816-22. doi: 10.2174/1871527315666160518125612. CNS Neurol Disord Drug Targets. 2016. PMID: 26825090 Review.
Conclusive Article: Sorting the Good from the Bad: The Different Approaches to Predict Cognitive Properties of New Symptomatic Drug Candidates for Neurodegenerative Diseases in Early Development.
Deguil J, Auffret A, Schenker E, Aujard F, Lamberty Y, Bartrès-Faz D, Herrero MT, Blin O, Micallef J, Richardson JC, Bordet R. Deguil J, et al. Among authors: bartres faz d. CNS Neurol Disord Drug Targets. 2016;15(7):837-8. doi: 10.2174/187152731507160808203445. CNS Neurol Disord Drug Targets. 2016. PMID: 27549168 Review. No abstract available.
An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Chan Kwong A, Cassé-Perrot C, Costes-Salon MC, Jouve E, Lanteaume L, Audebert C, Rouby F, Lefebvre MN, Ranjeva JP, Beck A, Deplanque D, Ponchel A, Vervueren C, Truillet R, Babilon C, Auffret A, Richardson JC, Payoux P, Bartrés-Faz D, Blin O, Bordet R, Micallef J; Pharmacog Consortium. Chan Kwong A, et al. Among authors: bartres faz d. J Clin Psychopharmacol. 2020 May/Jun;40(3):222-230. doi: 10.1097/JCP.0000000000001199. J Clin Psychopharmacol. 2020. PMID: 32332458 Clinical Trial.
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.
Galluzzi S, Marizzoni M, Babiloni C, Albani D, Antelmi L, Bagnoli C, Bartres-Faz D, Cordone S, Didic M, Farotti L, Fiedler U, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Parnetti L, Payoux P, Del Percio C, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium. Galluzzi S, et al. Among authors: bartres faz d. J Intern Med. 2016 Jun;279(6):576-91. doi: 10.1111/joim.12482. Epub 2016 Mar 4. J Intern Med. 2016. PMID: 26940242 Free article.
Translational Challenge Models in Support of Efficacy Studies: Neurobehavioral and Cognitive Changes Induced by Transcranial Magnetic Stimulation in Healthy Volunteers.
Martin-Trias P, Bragulat V, Peña-Gómez C, Sala-Llonch R, Lanteaume L, Cassé-Perrot C, Blin O, Micallef J, Auffret A, Bartrés-Faz D. Martin-Trias P, et al. Among authors: bartres faz d. CNS Neurol Disord Drug Targets. 2016;15(7):802-15. doi: 10.2174/1871527315666160518124316. CNS Neurol Disord Drug Targets. 2016. PMID: 27189466 Review.
Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
Drago V, Babiloni C, Bartrés-Faz D, Caroli A, Bosch B, Hensch T, Didic M, Klafki HW, Pievani M, Jovicich J, Venturi L, Spitzer P, Vecchio F, Schoenknecht P, Wiltfang J, Redolfi A, Forloni G, Blin O, Irving E, Davis C, Hårdemark HG, Frisoni GB. Drago V, et al. Among authors: bartres faz d. J Alzheimers Dis. 2011;26 Suppl 3:159-99. doi: 10.3233/JAD-2011-0043. J Alzheimers Dis. 2011. PMID: 21971460 Review.
207 results